ADC Therapeutics (ADCT) Market Capitalization (2020 - 2026)

ADC Therapeutics has disclosed Market Capitalization across 7 years of filings, most recently posting $136.4 million for Q2 2026.

• In Q2 2026, Market Capitalization fell 54.77% year-over-year to $136.4 million; the TTM figure through Jun 2026 stood at $136.4 million (down 54.77% YoY), while the FY2025 annual figure was $443.9 million, up 125.63% from the prior year.
• Market Capitalization came in at $136.4 million for Q2 2026 at ADC Therapeutics, down from $476.9 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $1.1 billion in Q1 2022 to a low of $80.1 million in Q3 2023.
• Average Market Capitalization over 5 years is $340.4 million, with a median of $304.7 million recorded in 2024.
• Year-over-year, Market Capitalization sank 84.61% in 2023 and jumped 280.05% in 2024.
• Over 5 years, Market Capitalization stood at $309.7 million in 2022, then tumbled by 55.89% to $136.6 million in 2023, then jumped by 44.02% to $196.7 million in 2024, then jumped by 125.63% to $443.9 million in 2025, then plunged by 69.28% to $136.4 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $136.4 million in Q2 2026, $476.9 million in Q1 2026, and $443.9 million in Q4 2025.